Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs Polaryx Therapeutics, Inc. (PLYX)

Milestone Pharmaceuticals Inc. and Polaryx Therapeutics, Inc. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and Polaryx Therapeutics, Inc. are of similar size ($86.7M and $86.2M). Polaryx Therapeutics, Inc. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Polaryx Therapeutics, Inc. leads on 10 and Milestone Pharmaceuticals Inc. on 2.

Valuation

Metric MIST PLYX Biotechnology median
P/E n/m n/m 10.60
P/S 19.90 n/m 9.40
P/B 5.79 8.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.08 n/m 0.66
EV/Sales (1.13) n/m 9.02
Earnings yield (90.79%) (11.77%) (32.88%)
Free cash flow yield (58.48%) (9.27%) (23.13%)

Profitability

Metric MIST PLYX Biotechnology median
Gross margin 13.27% — 68.51%
Operating margin (1,479.69%) 0.00% 0.00%
Net margin (1,586.01%) 0.00% 0.00%
Free cash flow margin (1,163.79%) 0.00% 0.00%
Return on equity (35,522.62%) 0.00% (51.96%)
Return on assets (73.36%) (169.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MIST PLYX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (11.94%) 77.72% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MIST PLYX Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 13.53 4.97
Net debt to EBITDA 0.79 0.66 1.01

Dividend

Metric MIST PLYX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MIST PLYX Biotechnology median
Market cap 86.21m 86.73m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack